AUKETT SWANKE GROUP PLC
AUK | IL
Overview
Corporate Details
- ISIN(s):
- GB0000617950
- LEI:
- 213800WWNHLPUBSUK220
- Country:
- United Kingdom
- Address:
- 10 BONHILL STREET, EC2A 4PE LONDON
- Website:
- https://aukettswanke.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Avacta Group plc is a UK life sciences company focused on improving healthcare through targeted cancer treatments and diagnostics.Ê They utilize Affimer and pre|CISION platforms to develop safe and effective drugs and research tools.Ê Their strategy centers on oncology, including partnerships to expand targeted cancer therapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-05 08:00 |
Capital/Financing Update
Convertible Loan Note Update
|
English | 9.3 KB | |
| 2025-08-01 08:00 |
Capital/Financing Update
Issue of Convertible Loan Notes
|
English | 27.1 KB | |
| 2025-07-10 08:00 |
Director's Dealing
Director Pension Transfer
|
English | 34.9 KB | |
| 2025-06-26 17:40 |
Post-Annual General Meeting Information
Result of Annual General Meeting
|
English | 26.3 KB | |
| 2025-05-27 16:15 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.6 KB | |
| 2025-03-03 11:30 |
Regulatory News Service
Change of Name
|
English | 14.7 KB | |
| 2025-01-14 12:15 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-12-05 14:08 |
Director's Dealing
Director and PCA Dealings
|
English | 37.0 KB | |
| 2024-11-28 08:00 |
Report Publication Announcement
Notice of presence at Anticipate London 2024
|
English | 14.9 KB | |
| 2024-11-14 08:00 |
Regulatory News Service
Change of Auditor
|
English | 10.4 KB | |
| 2024-09-18 08:00 |
Earnings Release
Property disposal completion & Corporate update
|
English | 19.3 KB | |
| 2024-08-20 18:15 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-08-20 14:15 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-08-06 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-08-01 11:00 |
Director's Dealing
Director Dealing
|
English | 27.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
| CRISM Therapeutics Corporation | Virgin Islands (British) | N/A | ||
|
Curasight A/S | Denmark | CURAS | |
|
Curevac | Germany | CVAC |